OAM
DGX icon

Occidental Asset Management’s Quest Diagnostics DGX Stock Holding History

Occidental Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.12M Buy
28,872
+1,180
+4% +$232K 0.61% 49
2026
Q1 		$5.43M Buy
27,692
+771
+3% +$150K 0.64% 50
2025
Q4 		$4.67M Buy
26,921
+881
+3% +$160K 0.56% 56
2025
Q3 		$4.96M Buy
26,040
+275
+1% +$48.8K 0.62% 49
2025
Q2 		$4.63M Buy
25,765
+415
+2% +$72.1K 0.64% 46
2025
Q1 		$4.29M Buy
25,350
+1,011
+4% +$166K 0.65% 45
2024
Q4 		$3.67M Buy
24,339
+1,799
+8% +$280K 0.57% 49
2024
Q3 		$3.5M Buy
22,540
+1,046
+5% +$156K 0.56% 50
2024
Q2 		$2.94M Buy
21,494
+1,023
+5% +$140K 0.52% 55
2024
Q1 		$2.72M Buy
20,471
+1,341
+7% +$174K 0.51% 61
2023
Q4 		$2.64M Buy
19,130
+73
+0.4% +$9.6K 0.55% 48
2023
Q3 		$2.32M Buy
19,057
+247
+1% +$32.9K 0.54% 49
2023
Q2 		$2.64M Buy
18,810
+721
+4% +$99.4K 0.6% 38
2023
Q1 		$2.56M Buy
18,089
+284
+2% +$40.6K 0.64% 37
2022
Q4 		$2.79M Buy
17,805
+442
+3% +$63.5K 0.76% 31
2022
Q3 		$2.13M Buy
17,363
+723
+4% +$95.2K 0.64% 41
2022
Q2 		$2.21M Sell
16,640
-1
-0% -$136 0.66% 37
2022
Q1 		$2.28M Buy
16,641
+312
+2% +$43.5K 0.58% 43
2021
Q4 		$2.83M Buy
16,329
+833
+5% +$127K 0.67% 30
2021
Q3 		$2.25M Buy
15,496
+758
+5% +$111K 0.58% 36
2021
Q2 		$1.95M Buy
14,738
+937
+7% +$123K 0.52% 44
2021
Q1 		$1.77M Buy
13,801
+2,619
+23% +$323K 0.53% 40
2020
Q4 		$1.33M Buy
11,182
+613
+6% +$74.7K 0.44% 55
2020
Q3 		$1.21M Sell
10,569
-118
-1% -$13.9K 0.5% 45
2020
Q2 		$1.22M Buy
10,687
+244
+2% +$25.9K 0.54% 42
2020
Q1 		$839K Buy
10,443
+1,103
+12% +$114K 0.42% 55
2019
Q4 		$997K Buy
9,340
+520
+6% +$54.2K 0.41% 57
2019
Q3 		$944K Buy
8,820
+1,129
+15% +$116K 0.4% 50
2019
Q2 		$783K Buy
7,691
+1,426
+23% +$137K 0.35% 60
2019
Q1 		$563K Buy
6,265
+1,499
+31% +$130K 0.27% 77
2018
Q4 		$397K Sell
4,766
-120
-2% -$11.3K 0.22% 88
2018
Q3 		$527K Buy
4,886
+278
+6% +$30.5K 0.26% 76
2018
Q2 		$507K Sell
4,608
-89
-2% -$9.27K 0.27% 69
2018
Q1 		$471K Hold
4,697
– – 0.25% 66
2017
Q4 		$463K Buy
+4,697
New +$445K 0.24% 71
2017
Q3 		– Sell
-2,070
Closed -$230K – 138
2017
Q2 		$230K Sell
2,070
-115
-5% -$12.2K 0.14% 123
2017
Q1 		$215K Sell
2,185
-611
-22% -$58.2K 0.14% 115
2016
Q4 		$257K Sell
2,796
-174
-6% -$15K 0.19% 97
2016
Q3 		$251K Buy
2,970
+96
+3% +$8.06K 0.2% 83
2016
Q2 		$234K Sell
2,874
-269
-9% -$20.5K 0.2% 82
2016
Q1 		$225K Hold
3,143
– – 0.27% 65
2015
Q4 		$223K Buy
+3,143
New +$211K 0.29% 61
2015
Q3 		– Sell
-3,143
Closed -$228K – 66
2015
Q2 		$228K Hold
3,143
– – 0.31% 59
2015
Q1 		$242K Hold
3,143
– – 0.3% 56
2014
Q4 		$211K Buy
+3,143
New +$198K 0.32% 58

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Occidental Asset Management's DGX Position: Q2 2026 in Review

Occidental Asset Management increased its Quest Diagnostics (DGX) stake by 4.3% in Q2 2026, buying an estimated $232K and bringing the position to 28,872 shares worth $6.12M. The position accounts for 0.61% of the portfolio, ranked #49.

Occidental Asset Management first reported a position in DGX in Q4 2014 and has held it in 45 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Occidental Asset Management held 28,872 shares of Quest Diagnostics worth $6.12M as of Q2 2026.
  • Occidental Asset Management bought 1,180 Quest Diagnostics shares in Q2 2026, an estimated $232K.
  • Quest Diagnostics made up 0.61% of Occidental Asset Management's portfolio in Q2 2026, its #49 holding.
  • Occidental Asset Management first reported a position in Quest Diagnostics in Q4 2014 and has held it in 45 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Occidental Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.